Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application

Diabetes Care

Volumn 36, Issue 4, 2013, Pages 786-792

  Fonda, Stephanie J ^a   Salkind, Sara J ^a   Walker, M Susan ^a   Chellappa, Mary ^a   Ehrhardt, Nicole ^b   Vigersky, Robert A ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Ft Belvoir Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BURNOUT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC DIET; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KINESIOTHERAPY; LONGITUDINAL STUDY; MALE; MONITOR; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REAL TIME CONTINUOUS GLUCOSE MONITOR; SELF MONITORING; TREATMENT DURATION;

AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 84875459683     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1225     Document Type: Article

References (31)

1. Ehrhardt NM, Chellappa M, Walker MS, Fonda SJ, Vigersky RA. The effect of realtime continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus. J Diabetes Sci Tech 2011;5:668-675
2. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short-and long-term effects of real-time continuous glucosemonitoring in patients with type 2 diabetes. Diabetes Care 2012;35:32-38
3. Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50
4. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007;9:203-210
5. Yoo HJ, An HG, Park SY, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2008;82:73-79
6. Raz I, Wilson PW, Strojek K, et al. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009;32:381-386
7. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH. Glucose variability; does it matter? Endocr Rev 2010;31:171-182
8. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687
9. Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57: 1349-1354
10. Su G, Mi S, Tao H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011;10:19
11. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625
12. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070
13. Baghurst PA, Rodbard D, Cameron FJ. The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed. J Diabetes Sci Tech 2010;4:1382-1385
14. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl. 1):S55-S67
15. Kohnert KD, Vogt L, Salzsieder E. Advances in understanding glucose variability and the role of continuous glucose monitoring. Eur Endocrinol 2011;6:53-56
16. Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 2011;13: 921-928
17. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfield D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care 2008;31: 1473-1478
18. Clipp EC, Pavalko EK, Elder GH. Trajectories of health: in concept and empirical pattern. Behav Health Aging 1992;2:159-179
19. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation ContinuousGlucoseMonitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
20. Beck RW, Hirsch IB, Laffel L, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383
21. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732
22. Zick R, Petersen B, Richter M, Haug C; SAFIR Study Group. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther 2007;9: 483-492
23. Buckingham B, Caswell K, Wilson DM. Real-time continuous glucose monitoring. Curr Opin Endocrinol Diabetes Obes 2007;14:288-295
24. Wagner J, Tennen H, Wolpert H. Continuous glucose monitoring: a review for behavioral researchers. Psychosom Med 2012;74:356-365
25. Allen NA, Jacelon CS, Chipkin SR. Feasibility and acceptability of continuous glucose monitoring and accelerometer technology in exercising individuals with type 2 diabetes. J Clin Nurs 2009;18:373-383
26. Volpp KG. Paying people to lose weight and stop smoking. LDI Issue Brief 2009; 14:1-4
27. Volpp KG, Asch DA, Galvin R, Loewenstein G. Redesigning employee health incentivesdlessons from behavioral economics. N Engl J Med 2011;365: 388-390
28. Parkin CG, Hinnen D, Campbell RK, Geil P, Tetrick DL, PolonskyWH. Effective use of paired testing in type 2 diabetes: practical applications in clinical practice. Diabetes Educ 2009;35:915-927
29. Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011;34:262-267
30. Durán A, Martín P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010;2:203-211
31. Franciosi M, Lucisano G, Pellegrini F, et al.; ROSES Study Group. ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011;28:789-796